I am going to go on a limb and say that for years RVX share price has been manipulated by the insiders themselves to get the most out of share conversations for the debentures over the past 10 years or so.  Why would Hepalink at this point want a high share price to convert the debenture when they short sell some of their holdings to keep a lid on the SP below $1.  I  wouldn't  be surprised if the majority of shorter are hepalink.  Once or if RVX completes a successful trial , with Covid or Betonmace2, a major BP will swoop in for a buyout IMO at a huge multiple. The guess of the buyout price is anyone guess but it has to be higher than Constellations buyout of$1.7 Billion USD IMO